Company profile for CEPI

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Epidemic diseases affect us all. They do not respect borders. CEPI is a innovative global partnership between public, private, philanthropic, and civil society organisations. We're working together to accelerate the development of vaccines against emerging infectious diseases and enable equitable access to these vaccines for people during outbreaks.The Coalition for Epidemic Preparedness Innovations (CEPI) is a global partners...
Epidemic diseases affect us all. They do not respect borders. CEPI is a innovative global partnership between public, private, philanthropic, and civil society organisations. We're working together to accelerate the development of vaccines against emerging infectious diseases and enable equitable access to these vaccines for people during outbreaks.The Coalition for Epidemic Preparedness Innovations (CEPI) is a global partnership launched in 2017 to develop vaccines to stop future epidemics.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
United Kingdom
Address
Address
Gibbs building, 215 Euston Rd, Bloomsbury, London NW1 2BE
Telephone
Telephone
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more
CEPI appoints Dr Yasuhiro Suzuki to the Board
CEPI appoints Dr Yasuhiro Suzuki to the Board

08 Apr 2023

// BIOSPECTRUM ASIA

https://www.biospectrumasia.com/news/30/22255/cepi-appoints-dr-yasuhiro-suzuki-to-the-board.html

BIOSPECTRUM ASIA
08 Apr 2023
SK bioscience and CEPI enter mRNA vaccine development deal
SK bioscience and CEPI enter mRNA vaccine development deal

27 Oct 2022

// PHARMACEUTICAL-TECHNOLOGY

https://www.pharmaceutical-technology.com/news/sk-bioscience-cepi-vaccine-deal/

PHARMACEUTICAL-TECHNOLOGY
27 Oct 2022

https://www.indianpharmapost.com/news/cepi-and-sk-bioscience-partner-to-advance-mrna-vaccine-technology-13207

INDIANPHARMAPOST
26 Oct 2022

https://www.prnewswire.com/news-releases/cepi-partners-with-intravacc-to-develop-an-intranasal-broadly-protective-betacoronavirus-vaccine-301641943.html

PRNEWSWIRE
06 Oct 2022

https://www.globenewswire.com/news-release/2022/07/05/2473809/0/en/CEPI-and-Codiak-BioSciences-partner-to-develop-broadly-protective-Betacoronavirus-vaccine.html

GLOBENEWSWIRE
05 Jul 2022

https://www.globenewswire.com/news-release/2022/04/06/2418030/0/en/CEPI-to-co-fund-Vaxxinity-s-pivotal-Phase-3-UB-612-heterologous-booster-trial-to-combat-SARS-CoV-2-variants.html

GLOBENEWSWIRE
06 Apr 2022

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty